10x Genomics
$59.959876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$59.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-0.07%) As of 10:05 AM EDT today
-$0.04 (-0.07%) Today
Why Robinhood?
You can buy or sell 10x Genomics and other stocks, options, ETFs, and crypto commission-free!
About TXG
10x Genomics, Inc. Class A Common Stock, also called 10x Genomics, is a life science technology company, which engages in building products to interrogate, understand and master biology. Read More Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.
Employees
584
Headquarters
Pleasanton, California
Founded
2012
Market Cap
5.79B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
784.97K
High Today
$61.16
Low Today
$59.00
Open Price
$61.16
Volume
16.52K
52 Week High
$108.36
52 Week Low
$45.11
Collections
TXG Earnings
-$0.33
-$0.22
-$0.11
$0.00
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, After Hours